ArticleFrontiers in pediatrics2023

Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children.

Jiao Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.